Recent Advances in (chemo-)radiation Therapy for Rectal Cancer: a Comprehensive Review

Overview

Journal Radiat Oncol

Publisher Biomed Central

Specialties Oncology
Radiology

Date 2020 Nov 11

PMID 33172475

Citations 30

Authors

F Roeder

E Meldolesi

S Gerum

V Valentini

C Rodel

Affiliations

Soon will be listed here.

Abstract

The role of radiation therapy in the treatment of (colo)-rectal cancer has changed dramatically over the past decades. Introduced with the aim of reducing the high rates of local recurrences after conventional surgery, major developments in imaging, surgical technique, systemic therapy and radiation delivery have now created a much more complex environment leading to a more personalized approach. Functional aspects including reduction of acute or late treatment-related side effects, sphincter or even organ-preservation and the unsolved problem of still high distant failure rates have become more important while local recurrence rates can be kept low in the vast majority of patients. This review summarizes the actual role of radiation therapy in different subgroups of patients with rectal cancer, including the current standard approach in different subgroups as well as recent developments focusing on neoadjuvant treatment intensification and/or non-operative treatment approaches aiming at organ-preservation.

Citing Articles

Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer.

Haynes J, Manogaran P Int J Mol Sci. 2025; 26(5).

PMID: 40076613 PMC: 11901061. DOI: 10.3390/ijms26051988.

tRNA-derived small RNAs: their role in the mechanisms, biomarkers, and therapeutic strategies of colorectal cancer.

Zhang B, Pan Y, Li Z, Hu K J Transl Med. 2025; 23(1):51.

PMID: 39806419 PMC: 11727791. DOI: 10.1186/s12967-025-06109-x.

Guideline for the assessment and management of gastrointestinal symptoms following colorectal surgery-A UEG/ESCP/EAES/ESPCG/ESPEN/ESNM/ESSO collaboration. Part I-Sequelae to oncological diseases.

Gielen A United European Gastroenterol J. 2024; 12(10):1489-1506.

PMID: 39576262 PMC: 11652338. DOI: 10.1002/ueg2.12658.

Advances in Chitosan-Based Smart Hydrogels for Colorectal Cancer Treatment.

Piotrowska U, Orzechowska K Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458901 PMC: 11510048. DOI: 10.3390/ph17101260.

An updated landscape on nanopharmaceutical delivery for mitigation of colon cancer.

Shahzad M, Hameed H, Amjad A, Khan M, Qureshi I, Hameed A Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39361171 DOI: 10.1007/s00210-024-03482-0.

References

Garcia M, Martinez-Villacampa M, Santos C, Navarro V, Teule A, Losa F . Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer. BMC Cancer. 2015; 15:59. PMC: 4342871. DOI: 10.1186/s12885-015-1052-0. View

Klautke G, Feyerherd P, Ludwig K, Prall F, Foitzik T, Fietkau R . Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer. Br J Cancer. 2005; 92(7):1215-20. PMC: 2361958. DOI: 10.1038/sj.bjc.6602492. View

Martling A, Holm T, Rutqvist L, Johansson H, Moran B, Heald R . Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg. 2004; 92(2):225-9. DOI: 10.1002/bjs.4834. View

Borg C, Andre T, Mantion G, Boudghene F, Mornex F, Maingon P . Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study. Ann Oncol. 2014; 25(11):2205-2210. DOI: 10.1093/annonc/mdu377. View

Mohiuddin M, Paulus R, Mitchell E, Hanna N, Yuen A, Nichols R . Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer. Int J Radiat Oncol Biol Phys. 2013; 86(3):523-8. PMC: 4201041. DOI: 10.1016/j.ijrobp.2013.02.020. View

Habr-Gama A, Perez R, Proscurshim I, Campos F, Nadalin W, Kiss D . Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg. 2006; 10(10):1319-28. DOI: 10.1016/j.gassur.2006.09.005. View

Valentini V, Coco C, Minsky B, Gambacorta M, Cosimelli M, Bellavita R . Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy. Int J Radiat Oncol Biol Phys. 2007; 70(2):403-12. DOI: 10.1016/j.ijrobp.2007.06.025. View

Gao Y, Lin J, An X, Luo J, Cai M, Cai P . Neoadjuvant sandwich treatment with oxaliplatin and capecitabine administered prior to, concurrently with, and following radiation therapy in locally advanced rectal cancer: a prospective phase 2 trial. Int J Radiat Oncol Biol Phys. 2014; 90(5):1153-60. DOI: 10.1016/j.ijrobp.2014.07.021. View

Bazarbashi S, Omar A, Aljubran A, Alzahrani A, Alsanea N, Abduljabbar A . Pre-operative chemoradiotherapy using capecitabine and cetuximab followed by definitive surgery in patients with operable rectal cancer. Hematol Oncol Stem Cell Ther. 2016; 9(4):147-153. DOI: 10.1016/j.hemonc.2016.08.004. View

10.

Lindebjerg J, Spindler K, Ploen J, Jakobsen A . The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy. Colorectal Dis. 2008; 11(3):264-9. DOI: 10.1111/j.1463-1318.2008.01599.x. View

11.

Kim S, Shim E, Yeo H, Baek J, Hong Y, Kim D . KRAS mutation status and clinical outcome of preoperative chemoradiation with cetuximab in locally advanced rectal cancer: a pooled analysis of 2 phase II trials. Int J Radiat Oncol Biol Phys. 2012; 85(1):201-7. DOI: 10.1016/j.ijrobp.2012.03.048. View

12.

But-Hadzic J, Anderluh F, Brecelj E, Edhemovic I, Secerov-Ermenc A, Hudej R . Acute Toxicity and Tumor Response in Locally Advanced Rectal Cancer After Preoperative Chemoradiation Therapy With Shortening of the Overall Treatment Time Using Intensity-Modulated Radiation Therapy With Simultaneous Integrated Boost: A Phase 2.... Int J Radiat Oncol Biol Phys. 2016; 96(5):1003-1010. DOI: 10.1016/j.ijrobp.2016.08.031. View

13.

Cubillo A, Hernando-Requejo O, Garcia-Garcia E, Rodriguez-Pascual J, de Vicente E, Morelli P . A prospective pilot study of target-guided personalized chemotherapy with intensity-modulated radiotherapy in patients with early rectal cancer. Am J Clin Oncol. 2012; 37(2):117-21. DOI: 10.1097/COC.0b013e31826e0703. View

14.

Sadahiro S, Suzuki T, Tanaka A, Okada K, Saito G, Kamijo A . Phase II study of preoperative concurrent chemoradiotherapy with S-1 plus bevacizumab for locally advanced resectable rectal adenocarcinoma. Oncology. 2014; 88(1):49-56. DOI: 10.1159/000367972. View

15.

Deng Y, Chi P, Lan P, Wang L, Chen W, Cui L . Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial. J Clin Oncol. 2019; 37(34):3223-3233. PMC: 6881102. DOI: 10.1200/JCO.18.02309. View

16.

Omidvari S, Zohourinia S, Ansari M, Ghahramani L, Zare-Bandamiri M, Mosalaei A . Efficacy and Safety of Low-Dose-Rate Endorectal Brachytherapy as a Boost to Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Distal Rectal Cancer: A Phase-II Clinical Trial. Ann Coloproctol. 2015; 31(4):123-30. PMC: 4564663. DOI: 10.3393/ac.2015.31.4.123. View

17.

Dellas K, Hohler T, Reese T, Wurschmidt F, Engel E, Rodel C . Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer. Radiat Oncol. 2013; 8:90. PMC: 3679876. DOI: 10.1186/1748-717X-8-90. View

18.

Kim S, Hong Y, Kim D, Kim T, Kim J, Im S . Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter Phase II study. Int J Radiat Oncol Biol Phys. 2010; 81(3):677-83. DOI: 10.1016/j.ijrobp.2010.06.035. View

19.

Marechal R, Vos B, Polus M, Delaunoit T, Peeters M, Demetter P . Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study. Ann Oncol. 2011; 23(6):1525-30. DOI: 10.1093/annonc/mdr473. View

20.

Stojanovic S, Popov I, Radosevic-Jelic L, Micev M, Borojevic N, Nikolic V . Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma. Cancer Chemother Pharmacol. 2010; 68(3):787-93. DOI: 10.1007/s00280-010-1469-8. View